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ABSTRACT 
Most of the newly invented chemical drug moieties are poorly water soluble. According to 
BCS classification, class II and IV drugs are considered as poorly water soluble. So 
enhancement of oral absorption and bioavailability of solid dosage forms remains a challenge 
to formulation scientists due to their solubility criteria. Therefore many techniques are being 
explored to enhance the solubility of poor soluble drugs. Solid dispersion is one of the most 
important method for enhance the solubility (dissolution rate) and hence oral bioavailability 
of poorly soluble drugs.  In solid dispersion the particle size of drug is reduced or a crystalline 
pure drug is converted into amorphous form and hence the solubility is increased. Polymer 
incorporating in solid dispersion technology is usually hydrophilic in nature and also showing 
compatibility with the drug to enhance the drug solubility. This review mainly discus about 
solid dispersion, preparation methods, and finally characterization.     
            
Introduction 
 
The solubility of drug is one of the most important criteria in 
formulation development. Oral bioavailability of drugs depends 
on its solubility and dissolution rate, these drugs having very low 
solubility in biological fluids, which results into poor 
bioavailability after oral administration[1]. Solid dispersion is 
one of the techniques to improve solubility and hence 
bioavailability of poorly water soluble drugs. Solid dispersion 
methodologies are have attracted considerable interest of 
enhancing the dissolution rate of highly lipophilic drugs thereby 
increasing their solubility by reducing drug particle size, 
improving wettability and forming the amorphous particles.[2] 
The term solid dispersion defined to a group of solid products 
consisting of at least two different components, generally a 
hydrophilic inert carrier and a hydrophobic drug[3]. 
Bioavailability refers as the rate and extent to which the active 
substance or therapeutic moiety is absorbed from a 
pharmaceutical dosage form and becomes available at the site of 
action.[4] An orally administered drug of its bioavailability 
depends on its solubility in aqueous media over the pH range of 
1.0–7.5 and the rate of mass transfer into biological membranes. 
[5-7]. In the oral bioavailability of poorly water soluble 
compounds, the insufficient dissolution rate is the limiting 
factor[8]. in the biopharmaceutical classification system (BCS) 
drugs with low aqueous solubility and high membrane 
permeability are categorized as Class II drugs. Therefore, solid 
dispersion technologies are particularly promising for improving 
the oral absorption and bioavailability of BCS Class II drugs. 
(9). In case of solid dispersion, drug is dispersed in the matrix 
generally a hydrophilic matrix and a hydrophobic drug, thereby 
forming a solid dispersion[10]. 
Solubility: Solubility can be defined as qualitatively as well as 
quantitatively. Quantitatively solubility can be defined as the 
solute concentration in a saturated solution at a particular 
temperature. Whereas qualitative it can be defined as the 
spontaneous interaction of two substances to produces a 
homogenous molecular dispersion[11].The amount of substance 
that passes into solution in order to establish the equilibrium at 
constant pressure and temperature and so produced a saturated 
solution is known as the ‘solubility[12]. Solubility is of the 
Consideration of the modified Noyes-Whitney equation provides 
some hints as to how improve the dissolution rate of even very 
poorly soluble compounds and to minimize the limitations to 
oral bioavailability of substance[13]. 
           dC/dt = AD (Cs - C)/h  
              Where, 
dC/dt is the rate of dissolution, A is the surface area 
available for dissolution, D is the diffusion coefficient of 
the compound, Cs is the solubility of the compound in a 
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dissolution medium, C is the concentration of drug present 
in the medium at a time t and h is the thickness of the 
diffusion boundary layer adjacent to the surface of the 
dissolving compound[14]. 
Solid Dispersion: In 1961, Sekiguchi and Obi first 
proposed the utilization of solid dispersions to enhance the 
dissolution and oral absorption of poorly water-soluble 
drugs. They first proposed the formation of a eutectic 
mixture of a poorly water-soluble drug is physiologically 
inert, easily soluble carriers and the carriers are introduced 
in the year 1969 by Chiou and Riegelman.  
Definition: The term ‘solid dispersion’ has been defined 
as the technique whereby the drug is dispersed in a 
biologically inert matrix, to improving oral bioavailability. 
Solid dispersion was firstly introduced to overcome the 
low bioavailability of lipophilic drugs by forming of 
eutectic mixtures of drugs with water-soluble carriers. In 
the Biopharmaceutical Classification System (BCS) Class 
II drugs are those are having low aqueous solubility and 
high membrane permeability (Amidon et al., 1995) and 
therefore, solid dispersion technologies are particularly 
promising for enhancing the oral absorption and 
bioavailability of BCS Class II drugs. According to the 
BCS, drug substances are classified in four groups as 
shown in Table 1 (FDA 2000). The table is adopted from 
Lindenberg et al., 2004, only for the BCS Class II drugs 
[15]. 
 
Table 1: Biopharmaceutical Classification System (BCS) 
Class Permeability Solubility 
Class I High High 
Class II High Low 
Class III Low High 
Class IV Low Low 
 
Merits of solid dispersion 
 Increased wettability during solid dispersion, results in 
enhancing the solubility. Here the carriers play the key role 
to improve the wettability of the solid particles. 
 In solid dispersion method, the particles are having high 
degree of porosity. Increase in porosity influence carrier 
properties and increase drug release profile.[17] 
 Amorphous state of drug leads to enhancement in drug 
release. By using solid dispersion method, drugs are 
presented as supersaturated solutions, which are considered 
to be metastable Polymorphic form. 
 Particle size reduction in solid dispersion leads to increase 
surface area which cause increase in dissolution rate hence 
improved bioavailability.[18] 
Demerits of Solid Dispersions: 
 Stability problem of vehicle and drug. 
 Physicochemical properties reproducibility. 
 Method of preparation is expensive. 
 Difficult to prepare solid dispersions in a dosage form.[19] 
Types of Solid Dispersions 
Based on their molecular arrangement, four different types 
of solid dispersions can be distinguished. 
They are described below. 
1. Eutectics 
2. Amorphous precipitations in crystalline matrix 
3. Solid solutions 
a. Continuous solid solutions 
b. Discontinuous solid solutions 
c. Substitutional solid solutions 
d. Interstitial solid solutions 
4. Glass suspensions and solutions 
Eutectic Mixtures 
Eutectic mixtures are formed by the drug and polymer is 
miscible in their molten state, but on cooling, they 
crystallize as two distinct components with negligible 
miscibility. In this type of solid dispersion a drug (A) and a 
carrier (B) are co-melted at their eutectic composition 
defined by point ‘e’. [20] 
 
 
Figure 1: Eutectics system phase diagram 
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Amorphous precipitation in crystalline matrix: In this 
type within the amorphous solvent the solute molecules 
are dispersed irregularly and molecularly[21]. In earlier 
studies other carriers were used in this type of dispersion 
such as urea and sugars (sucrose, galactose and dextrose). 
But now a day’s cellulose derivatives and organic 
polymers are used (PVP, PEG etc). To plasticize the 
polymer various solute molecules are used. The reduction 
in glass transition temperature is due to solutes which are 
used to mould the polymer[22].  
            
 
 
                       
Figure 2: Amorphous solutions 
 
Solid solutions: In a solid solution the two components 
are crystallize together in a homogeneous one phase 
system. The particle size of the drug in the solid 
solutions is reduced to its molecular size. Thus, a solid 
solution can achieve a faster dissolution rate than the 
corresponding eutectic mixture. Solid solutions can be 
classified by two methods. According to the extent of 
miscibility of the two components, the solid solutions 
may be classified as continuous or discontinuous[23] 
 Continuous solid solutions - In continuous solid 
solutions, the components are miscible in all proportions 
i.e. the bonding strength between the two components is 
stronger than the bonding between the individual 
component.  
 
 
Figure 3: Continuous solid solution phase diagram 
 Discontinuous solid solutions - In discontinuous 
solid solutions, the solubility of each of the 
component in the other component is limited in 
nature[24]. 
 
 
 
Figure 4: Discontinuous solid solutions phase diagram 
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 Substitutional solid solutions: In this solution system 
the solvent molecules are within the crystal lattice of the 
solid solvent molecules are substituted by the solid 
molecules by substitutional solid solutions. 
 
 
Figure 5: Substitutional solid solutions 
 Interstitial solid solutions 
In the crystal lattice the dissolved molecules are occupies 
the interstitial spaces between the solvent molecules. The 
molecular diameter of the solute molecules in case of 
interstitial solid solutions should not be greater than 
solvent molecules diameter i.e 0.59 and solvent molecules 
have more than 20% diameter than solute molecules[25]. 
 
 
 
Figure 6: Interstitial solid solutions 
Glass Solutions and Glass Suspensions 
A glass solution or glass suspensions are a homogenous, in 
glassy system in which a solute dissolves in a glassy 
solvent. The term glass can be used to describe either a 
pure chemical or a mixture of chemicals in a glassy or 
vitreous state. The glassy or vitreous state is usually 
obtained by an abrupt quenching of the melt. It is 
characterized by transparency & brittleness below the 
glass transition temperature [26] 
 
Table 2: Mechanisms to Increase Dissolution Rate [28] 
MECHANISM      CHARACTERISTICS 
1. Reduction of particle size:   
 
1. Particle size is reduced to a low level in case of glass, either solid solution or 
amorphous dispersions. 
2. This lead to an enhancing dissolution rate by an increase in both the surface area.  
2. Solubilization effect          1. When the carrier material dissolves it has solubilization effect on the drug. 
2. Drugs with increase solubilization effect of like acetaminophen and chlorpropamide in 
urea. 
3. Metastable Forms              Reduced lattice energy due to formation of metastable dispersions results in faster 
dissolution rate. 
4.Wettability and dispersibility Carrier used has enhancing effect on wettability and dispersibility. 
                                                
Selection of Carrier 
 
A carrier should have the following suitable 
characteristics for enhance the solubility and 
dissolution rate of a drug.  
1. Freely water-soluble with having the intrinsic rapid 
dissolution properties.  
2. Pharmacologically inert and Non-toxic to drug 
molecules.   
3. Should have thermo stable with a low melting point 
for the melt method.  
4. Soluble in a variety of solvents and pass through a 
vitreous state upon solvent evaporation for the solvent 
method.  
5. Capable to preferably improve the aqueous solubility 
of the drug and 
6. Chemically compatible with the drug and should not 
form a strongly bonded complex with the drug[26]. 
Classification of Solid Dispersion 
First generation: The first generation solid dispersions 
can be developed by using crystalline carriers like urea 
and sugar, which were the first carriers to be imparted 
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in solid dispersion. They are having the disadvantage of 
forming crystalline solid dispersion, which were 
thermodynamically more stable and cannot release the 
drug as quickly as amorphous ones. 
 
 
Figure 7: Generations of carriers of solid dispersion 
Second generation: In second generation solid dispersions, 
amorphous carriers are used instead of crystalline carriers, 
which are usually polymers. These polymers are include 
synthetic polymers such as poly vinyl pyrolidone (PVP), 
polyethylene glycols (PEG), ethyl cellulosepolymethacrylates, 
natural product based polymers such as 
hydroxylpropylmethyl-cellulose (HPMC) and hydroxypropyl 
cellulose or starch derivatives like cyclodextrins.  
Third generation: Recently, it has been observed that the 
dissolution profile can be improved further, if the carrier has 
surface activity or self-emulsifying properties. Therefore, third 
generation solid dispersions were developed. The use of 
surfactant such as inutec SP1, inulin, compritol 888 ATO, 
gelucire 44/14 and poloxamer 407 as carriers were shown to 
be effective in originating high polymorphic purity and 
enhanced in vivo bioavailability.[27] 
 
Preparation Methods of Solid Dispersion 
1. Fusion / Melting method  
2. Solvent method  
3. Melting solvent method (melt evaporation)  
4. Melt extrusion methods  
5. Lyophilization techniques  
6. Melt agglomeration Process  
7. The use of surfactant  
8. Electrospinning  
9. Super Critical Fluid (Scf) technology 
10. Direct Capsule Filling 
11. Co-precipitation method 
12. Dropping method 
Melting Method: Accurately weighed drug and carrier are 
mixed by using glass mortar and pestle. The mixture is heated 
at or above the melting point of all the components to achieve 
a homogenous dispersion. It is then cooled to obtain a 
congealed mass. It is pulverized and sieved[28]. 
Solvent evaporation method:The solvent-based process uses 
the organic solvent to dissolve and intimately disperse the 
drug and carrier molecule. Large volumes of solvents are 
generally required which can give rise to toxicological 
problems. Many investigators studied SD of meloxicam, 
naproxen, rofecoxib, felodipine using solvent evaporation 
technique. These findings suggest that the above-mentioned 
technique can be employed successfully for improvement and 
stability of solid dispersions of poor water drugs[28]. 
Hot melt extrusion:Hot-stage extrusion (HME) consists of 
the extrusion. The extraction is processed at high rotational 
speed of the drug and carrier, previously mixed, at melting 
temperature for a small period of time. The resulting product 
is then collected after cooling at room temperature and milled. 
A reduction in processing temperature can be achieved by the 
association of hot-stage extrusion with the use of carbon 
dioxide as a plasticizer, which broadens the application of hot-
stage extrusion to thermally labile compounds. HME also 
offers several advantages over traditional pharmaceutical 
processing techniques including the absence of solvents, few 
processing steps, continuous operation, more possibility of the 
formation of solid dispersions and improved bioavailability. 
[29] 
Melting –solvent method: A drug is first dissolved in a 
suitable liquid solvent and then this solution is incorporated 
into the melt of polyethylene glycol, obtainable below 70
o
C 
without removing the liquid solvent. The selected solvent or 
dissolved drug may not be miscible with the melt of the 
polyethylene glycol. Also polymorphic form of the drug 
precipitated in the solid dispersion may get affected by the 
liquid solvent used. [27] 
Lyophillization Technique: Freeze-drying involves transfer 
of heat and mass to and from the product under preparation. 
This technique was proposed as an alternative technique to 
solvent evaporation. Lyophillization has been thought of a 
molecular mixing technique where the drug and carrier are co 
dissolved in a common solvent, frozen and sublimed to obtain 
a lyophilized molecular dispersion. 
 Melt Agglomeration technique: In this technique binders 
are used as carriers. There are two methods of preparations of 
solid dispersing, first is by spraying the drug on melted binder 
plus excipients. Other one is melting of binder drug and 
excipients above the melting temperature of binders used. For 
using high binder content rotary process might be preferable 
for controlling temperature. This technique is advantageous in 
homogenous mixing of drug but larger particle size cause 
densification and fines cause adhesion of mass. 
The use of surfactant: The utility of the surfactant systems in 
solubilization is well known. Surfactant reduces 
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hydrophobicity of drug by reducing interfacial or surface 
tension. Because of this unique property of surfactants have 
attracting the attention of investigators for preparation of solid 
dispersions. Recently a new class of surfactant known as 
gelucires are introduced which identify by melting points and 
HLB values. Gelucire is widely used in the formulation of 
semi solid dispersions. Gelucires with low HLB can be 
employed to decrease the dissolution rate of drugs and higher 
HLB ones for fast release. Hemant et al and Sheen et al 
studied that polysorbate 80, a commonly used surfactant, 
results in improvement of dissolution and bioavailability of 
poorly water soluble drug attributed to solubilization effect of 
surface active agent. Polysorbate 80 also ensures complete 
release of drug in metastable finely dispersed state having 
large surface area. 
Electrospinning: Electrospinning is a process in which solid 
fibers are produced from a polymeric fluid stream solution or 
melt delivered through a millimeter-scale nozzle. This process 
involves the application of a strong electrostatic field over a 
conductive capillary attaching to a reservoir containing a 
polymer solution or melt and a conductive collection screen. 
Upon increasing the electrostatic field strength up to formation 
of charged species, but not exceed a critical value. The 
charged species are accumulated on the surface of a pendant 
drop; destabilize the hemispherical shape into a conical shape 
(commonly known as Taylor’s cone). Beyond the critical 
value, a charged polymer jet is ejected from the apex of the 
cone (as a way of relieving the charge built-up on the surface 
of the pendant drop). The ejected charged jet is then carried to 
the collection screen via the electrostatic force. The thinning 
down of the charged jet is limited. If the viscosity increases, 
the charged jet is dried. This technique has tremendous 
potential for the preparation of nanofibres and controlling the 
release of biomedicine, as it is simplest, the cheapest this 
technique can be utilized for the preparation of solid 
dispersions in future.  
Supercritical Fluid Method: Supercritical fluid technology is 
important because it operates at high temperature and 
pressure. Above critical temperature and pressure supercritical 
fluid exists as single phase. The most commonly used SCF is 
CO2 due to its low temperature (31.3 degree C) and low 
pressure (73.8 bar). It is used because it non toxic, non 
inflammable, inexpensive and for processing heat labile 
molecules. In this drug and inert carrier are dissolved in 
carbon dioxide solvent and are sprayed by nozzle with low 
pressure on expansion vessel and particles are formed. And 
then the expansion of mixture is rapidly cooled. Another name 
of this technique is Rapid Expansion of supercritical solution. 
Direct Capsule Filling: In this technique large scale 
manufacturing equipment and laboratory scale semiautomatic 
equipment is used. Liquid melt of solid dispersion is directly 
filled in to hard gelatin capsule due to this it overcomes the 
problem due to grinding which cause change in crystalline 
behaviour of drug. Eg. Molten dispersion of triamterene-PEG 
1500 can be filled in hard gelatine capsule by the use of 
Zanasi LZ 64 capsule filling machine. 
Co-precipitation method:Co-precipitation is a recognized 
technique for increasing the dissolution of poorly water 
soluble drugs, so as to consequently improve bioavailability. 
In this method non solvent is added drop wise to the drug and 
carrier solution, under constant stirring. In the course of the 
non solvent addition, the drug and carrier are co-precipitated 
to form micro particles. At the end, the resulted micro particle 
suspension is filtered and dried. The required quantity of 
polymer and the drug were mixed and then solvent was added 
to obtain clear solution. The Solution was first dried under 
vacuum at room temperature and kept inside incubator (370c) 
for 12 hrs. Finally it was passed through sieves. 
Dropping method: This technique may overcome some of the 
difficulties inherent in the other method and developed by 
Ulrich et al.12 to facilitate the crystallization of different 
chemicals, is a new procedure for producing round particles 
from melted solid dispersions. A solid dispersion of a melted 
drug carrier mixture is pipette and then dropped onto a plate, 
where it solidifies into round particles. The size and shape of 
the particles can be influenced by factors such as the viscosity 
of the melt and the size of the pipette. The dropping method 
does not use organic solvents and, therefore, has none of the 
problems associated with solvent evaporation. This method 
also avoids the pulverization, sifting and compressibility 
difficulties. 
Characterization of solid dispersions: 
Various characterization methods to assess the solid dispersion 
are as follows 
Drug -carrier miscibility  
• Hot stage microscopy  
• Differential scanning calorimetry  
• Powder X-ray diffraction  
•Spectroscopic methods like raman spectroscopy, FT-IR 
spectroscopy 
Physical Structure  
• Scanning electron microscopy  
• Surface area analysis  
• Surface properties  
• Dynamic vapour sorption  
• Inverse gas chromatograph  
• Atomic force microscopy  
• Raman microscopy  
Amorphous content  
• Polarized light optical microscopy  
• Hot stage microscopy  
• Humidity stage microscopy  
• DSC (MTDSC)  
• Powder X-ray diffraction  
Stability  
• Humidity studies  
• Isothermal Calorimetry  
• DSC (Tg, Temperature recrystallization)  
• Saturated solubility studies  
Dissolution enhancement  
• Dissolution  
• Intrinsic dissolution  
• Dynamic solubility  
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• Dissolution in bio-relevant media[27-29] 
 
Conclusion 
Now days so many techniques and methods are there to 
improve the solubility and oral bioavailability of solid dosage 
forms of having poorly water soluble drugs. Solid dispersion 
is one of the approaches to achieve the goal of enhancing the 
solubility of poorly soluble drugs. In this review some 
methods of solid dispersion techniques were explained briefly. 
Manufacturing of solid dispersions requires a suitable 
combination of drug and carriers. Whatever this technology is 
also highly potential to formulate controlled release dosage 
forms as the carriers may enhance or delay drug release. 
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